TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
UroMedical Väst AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
61,136
|
68,403
|
62,783 |
| Financial expenses |
10,016
|
417
|
5,282 |
| Earnings before taxes |
-3,781
|
10,970
|
-443 |
| EBITDA |
7,160
|
11,928
|
5,991 |
| Total assets |
17,431
|
21,893
|
30,828 |
| Current assets |
8,843
|
9,447
|
18,392 |
| Current liabilities |
7,245
|
7,214
|
16,148 |
| Equity capital |
9,351
|
13,844
|
13,845 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
22
|
22
|
22 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
53.6%
|
63.2%
|
44.9% |
| Turnover per employee |
2,779
|
3,109
|
2,854 |
| Profit as a percentage of turnover |
-6.2%
|
16.0%
|
-0.7% |
| Return on assets (ROA) |
35.8%
|
52.0%
|
15.7% |
| Current ratio |
122.1%
|
131.0%
|
113.9% |
| Return on equity (ROE) |
-40.4%
|
79.2%
|
-3.2% |
| Change turnover |
-7,267
|
5,620
|
2,452 |
| Change turnover % |
-11%
|
9%
|
4% |
| Chg. No. of employees |
0
|
0
|
3 |
| Chg. No. of employees % |
0%
|
0%
|
16% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.